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Renal denervation (RDN), a recently
developed therapy for resistant hyperten-
sion, is generally regarded as a safe proce-
dure (Krum et al., 2009; Esler et al., 2010;
Bhatt et al., 2014). The Symplicity HTN
trials reported that the rate of renal artery
stenosis after RDN was low. For exam-
ple, the Symplicity HTN-1 trial showed
that 1 of 45 (2.2%) denervated patients
developed a non-obstructive renal artery
stenosis in an untreated area at 6 months
after RDN (Krum et al., 2009). This low
rate of renal artery stenosis after RDN was
confirmed by the 6-month report of the
Symplicity HTN-2 trial (N = 106) (Esler
et al., 2010) and the recently published
6-month report of the Symplicity HTN-
3 trial (N = 535) (Bhatt et al., 2014),
which was 1.9 and 0.3%, respectively. In
these Symplicity HTN trials, renal artery
stenosis occurred at a low rate (0.3–2.2%)
and was not reported to cause further
complications.
However, some studies reported that
renal artery stenosis occurred at a higher
rate. For example, the EnligHTN I study
(Worthley et al., 2013) reported that 2
of 46 (4.3%) patients showed progres-
sion of a pre-existing renal artery stenosis;
a study from 10 European expert cen-
ters (Persu et al., 2014) reported that 3
of 109 (2.8%) patients showed progres-
sion of a non-significant (<30%) renal
artery stenosis; and Versaci et al. (2014a)
reported that 2 of 11 (18.2%) patients
developed severe renal artery stenosis.
It is worthwhile to point out that the
sample size of 11 in Versaci et al.’s
report is relatively small (Versaci et al.,
2014a).
In 2012, Vonend et al. reported that
a patient developed a 75% stenosis near
the ostium of the right renal artery, which
caused recurrent hypertension (Vonend
et al., 2012). Subsequently, another 3 case
reports reported that renal artery stenosis
after RDN caused recurrent hypertension
(Kaltenbach et al., 2012; Aguila et al., 2014;
Pucci et al., 2014).
The causal role of RDN in promoting
renal artery stenosis is currently
speculative. However, given that (1) renal
artery stenosis causes recurrent hyperten-
sion in denervated patients (Kaltenbach
et al., 2012; Vonend et al., 2012; Aguila
et al., 2014; Pucci et al., 2014) and (2)
treatment of renal artery stenosis is not
always safe and sometimes leads to death
(Soriano-Perez et al., 2012), it is impor-
tant to thoroughly investigate the effect of
RDN on renal artery stenosis (Mahfoud
and Kjeldsen, 2013; Wang, 2014a,b,c,d).
To do this, the following three points need
to be emphasized in future clinical trials
on RDN:
(1) Long-term randomized trials are
needed. Two major randomized
trials on RDN, i.e., the Symplicity
HTN-2 and HTN-3 trials (Esler
et al., 2012; Kandzari et al., 2012),
allowed patients in the random-
ized control group to receive RDN
after completion of the 6-month
study. This crossover design makes
it difficult to investigate possible
long-term side effects of RDN, e.g.,
promoting renal artery stenosis.
Therefore, long-term randomized tri-
als without a short-term crossover
design are needed to investigate the
effect of RDN on renal artery stenosis.
(2) Imaging methods monitoring renal
artery stenosis need to be stan-
dardized. Symplicity HTN trials did
not standardize renal artery imag-
ing methods during follow ups.
Ultrasonography, magnetic reso-
nance angiography, and computerized
tomographic angiography were used
(Krum et al., 2009; Esler et al., 2010).
The computerized tomographic
angiography, the gold standard
method to detect renal artery steno-
sis (Persu et al., 2012), was not the
major imaging method in these trials.
It is known that ultrasonography has
limited visualization on renal artery
stenosis because (1) the imaging is
interfered by overlying adipose tissue
and bowel gas (Zhang et al., 2009);
and (2) the entire length of the renal
artery or an accessory renal artery
can be overlooked (Lao et al., 2011).
Therefore, it is worthwhile to use
computerized tomographic angiog-
raphy as the standardized method
during follow ups in future trials to
investigate the effect of RDN on renal
artery stenosis.
(3) It is likely that improved catheters
for RDN using lower power radiofre-
quency over a shorter time will reduce
the local tissue injury at the abla-
tion site compared with that caused
by the first generation RDN sys-
tems (Versaci et al., 2014b). However
data regarding the vascular injury
induced by these new devices are
lacking.
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